Atlas Trials

Study of FP-1039 in Subjects With Endometrial Cancers

Clinical trial NCT01244438 · WITHDRAWN

Trial details

NCT number
NCT01244438
Sponsor
Five Prime Therapeutics, Inc.
Status
WITHDRAWN
Phase
Phase 2
Study type
INTERVENTIONAL
Endometrial Cancers With FGFR2 Mutations
Start date
2011-01-01
Primary completion
2012-06-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.